Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer

Cancer Chemotherapy and Pharmacology

Volumn 56, Issue 1, 2005, Pages 22-28

  Murakami, Jun ^a   Asaumi, Jun Ichi ^a   Kawai, Noriko ^a   Tsujigiwa, Hidetsugu ^a   Yanagi, Yoshinobu ^a   Nagatsuka, Hitoshi ^a   Inoue, Tetsuyoshi ^a   Kokeguchi, Susumu ^a   Kawasaki, Shoji ^a   Kuroda, Masahiro ^a   Tanaka, Noriaki ^a   Matsubara, Nagahide ^a   Kishi, Kanji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

FR901228; HDAC inhibitor; hTERT; Oral cancer

Indexed keywords

CYCLOHEXIMIDE; FR 901228; HISTONE DEACETYLASE INHIBITOR; MYC PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; ANTINEOPLASTIC ANTIBIOTIC; DEPSIPEPTIDE; DNA BINDING PROTEIN; HISTONE DEACETYLASE; MESSENGER RNA; TELOMERASE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DEACETYLATION; DRUG ACETYLATION; DRUG EFFECT; EPIGENETICS; HUMAN; HUMAN CELL; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION PROFILING; MOUTH TUMOR; PATHOLOGY;

ANTIBIOTICS, ANTINEOPLASTIC; DEPSIPEPTIDES; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; HISTONE DEACETYLASES; HUMANS; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 21244453835     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0976-x     Document Type: Article

References (37)

1. Bernhard D, Ausserlechner MJ, Tonko M, Lofler M, Hartmann BL, Csordas A, Kofler R (1999) Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J 13:1991
2. Blackburn EH, Greider CW (1995) Telomeres. Cold Spring Harbor Laboratory, Cold Spring Harbor
3. Blasco MA, Rizen M, Greider CW, Hanahan D (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12:200
4. Buckley AR, Leff MA, Buckley DJ, Magnuson NS, De Jong G, Gout PW (1996) Alterations in pim-1 and c-myc expression associated with butyrate-induced growth factor dependence in autonomous rat NB2 lymphoma cells. Cell Growth Differ 7:1713
5. Cong Y-S, Bacchetti S (2000) Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J Biol Chem 275:35665-35668
6. Cong Y-S, Wen J, Bacchetti S (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8:137-142
7. Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC (1999) DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res 59:6087
8. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18:1219
9. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO (1997) A mammalian telomerase-associated protein. Science 275:973
10. Heruth DP, Zirnstein GW, Bradley JF, Rothberg PG (1993) Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem 268:20466
11. Horikawa I, Barrett JC (2003) Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24:1167
12. Horikawa I, Cable PL, Afshari C, Barrett JC (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59:826
13. Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Bjorkholm M, Henriksson M, Gruber A, Xu D (2002) The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res 274:25
14. Imai T, Adachi S, Nishijo K, Ohgushi M, Okada M, Yasumi T, Watanabe K, Nishikomori R, Nakayama T, Yonehara S, Toguchida J, Nakahata T (2003) FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Oncogene 22:9231
15. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011
16. Kim HR, Christensen R, Park NH, Sapp P, Kang MK, Park NH (2001) Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Clin Cancer Res 7:3079
17. Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79
18. Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S (2001) Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res 61:5796
19. Krupitza G, Harant H, Dittrich E, Szekeres T, Huber H, Dittrich C (1995) Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells. Carcinogenesis 16:1199-1205
20. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M (1999) Estrogen activates telomerase. Cancer Res 59:5917
21. LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ, Chabot B (1998) Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet 19:199-202
22. Li H, Lee TH, Avraham H (2002) A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J Biol Chem 277:20965
23. Maier S, Reich E, Martin R, Bachem M, Altug V, Hautmann RE, Gschwend JE (2000) Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines. Int J Cancer 88:245
24. Misiti S, Nanni S, Fontemaggi G, Cong Y-S, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S, Farsetti A (2000) Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol 20:3764
25. Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59:521
26. Murakami J, Asaumi J, Maki Y, Tsujigiwa H, Kuroda M, Nagai N, Yanagi Y, Inoue T, Kawasaki S, Tanaka N, Matsubara N, Kishi K (2004) Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. Oral Oncol 40:597
27. Nakamura TM, Morin GB, Chapman B, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and humans. Science 277:955
28. Nakamura Y, Tahara E, Tahara H, Yasiu W, Tahara E, Ide T (1999) Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog 26:312
29. Sato N, Ohta T, Kitagawa H, Kayahara M, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K (2004) FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells. Int J Oncol 24:679
30. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59:551
31. Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res 29:3006
32. Thompson EB (1998) The many roles of c-Myc in apoptosis. Annu Rev Physiol 60:575
33. Wang S, Zhu J (2003) Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. J Biol Chem 278:18842
34. Wang J, Xie LY, Allan S, Beach D, Hannon GJ (1998) Myc activates telomerase. Genes Dev 12:1769
35. Weidle UH, Grossmann A (2000) Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res 20:1471
36. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 211:220
37. Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the hTERT promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A 98:3826